201 related articles for article (PubMed ID: 6208091)
21. Tumour-associated trypsin inhibitor (TATI) in human ovarian cyst fluid. Comparison with CA 125 and CEA.
Halila H; Huhtala ML; Haglund C; Nordling S; Stenman UH
Br J Cancer; 1987 Aug; 56(2):153-6. PubMed ID: 3117086
[TBL] [Abstract][Full Text] [Related]
22. Measurement of CA125, carcinoembryonic antigen, and alpha-fetoprotein in ovarian cyst fluid: diagnostic adjunct to cytology.
Pinto MM; Bernstein LH; Brogan DA; Parikh F; Lavy G
Diagn Cytopathol; 1990; 6(3):160-3. PubMed ID: 1696873
[TBL] [Abstract][Full Text] [Related]
23. Oncofetal antigens in sacrococcygeal teratomas.
Kuhajda FP; Taxy JB
Arch Pathol Lab Med; 1983 May; 107(5):239-42. PubMed ID: 6188436
[TBL] [Abstract][Full Text] [Related]
24. The significance of measurement of several oncofetal antigens in diagnosis and management of epithelial ovarian tumors.
Massi GB; Amunni G; Tommasi M; Bonazza M; Ciardetti P; Cappelli G
Eur J Gynaecol Oncol; 1983; 4(2):88-93. PubMed ID: 6191984
[TBL] [Abstract][Full Text] [Related]
25. Immunocytochemical evaluation of primary human esophageal carcinomas and their xenografts for keratin, beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
Burg-Kurland CL; Purnell DM; Combs JW; Valerio MG; Harris CC; Trump BF
Cancer Res; 1986 Nov; 46(11):5730-7. PubMed ID: 2428482
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of oncofetal antigens in patients with ovarian cancer.
Koh SH; Cauchi MN
Aust N Z J Obstet Gynaecol; 1983 May; 23(2):69-72. PubMed ID: 6194783
[TBL] [Abstract][Full Text] [Related]
27. Oncofoetal antigens in cancer of the cervix and ovary.
Cauchi MN; Koh SH; Lim D; Hay DL
Br J Cancer; 1981 Sep; 44(3):403-9. PubMed ID: 6169360
[TBL] [Abstract][Full Text] [Related]
28. The value of tumor markers in cancer of the ovary.
Cantarow WD; Stolbach LL; Bhattacharya M; Chatterjee SK; Barlow JJ
Int J Radiat Oncol Biol Phys; 1981 Aug; 7(8):1095-8. PubMed ID: 6170620
[No Abstract] [Full Text] [Related]
29. The clinical significances of carcinoembryonic proteins in patients with ovarian carcinoma.
Tottori K; Takeuchi S
Nihon Sanka Fujinka Gakkai Zasshi; 1981 Jan; 33(1):142-50. PubMed ID: 6164739
[TBL] [Abstract][Full Text] [Related]
30. Radioimmunoassay and saturation analysis. Tumor-associated antigens.
Bagshawe KD
Br Med Bull; 1974 Jan; 30(1):68-73. PubMed ID: 4143181
[No Abstract] [Full Text] [Related]
31. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.
Purnell DM; Heatfield BM; Trump BF
Cancer Res; 1984 Jan; 44(1):285-92. PubMed ID: 6197163
[TBL] [Abstract][Full Text] [Related]
32. Editorial: When is a tumor marker not a tumor marker?
Vaitukaitis JL
N Engl J Med; 1975 Dec; 293(26):1370-1. PubMed ID: 52844
[No Abstract] [Full Text] [Related]
33. [Cellular localization of alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG), and carcinoembryonic antigen (CEA) in malignant germ cell tumors of the ovary using immunoperoxidase technique (author's transl)].
Obata N; Kodama S; Hando T; Takeuchi S
Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jun; 32(6):757-66. PubMed ID: 6165791
[TBL] [Abstract][Full Text] [Related]
34. Contributions of immunocytochemistry to the diagnosis and study of ovarian neoplasms.
Kurman RJ; Ganjei P; Nadji M
Int J Gynecol Pathol; 1984; 3(1):3-26. PubMed ID: 6203854
[No Abstract] [Full Text] [Related]
35. [Diagnostic criteria for the tumor markers of the body fluids].
Konishi K; Nakagawa S; Watanabe K; Takamura S
Rinsho Byori; 1983 Sep; 31(9):945-54. PubMed ID: 6198536
[No Abstract] [Full Text] [Related]
36. Serial determination of marker substances in ovarian cancer.
Stanhope CR; Smith JP; Britton JC; Crosley PK
Gynecol Oncol; 1979 Dec; 8(3):284-7. PubMed ID: 92437
[No Abstract] [Full Text] [Related]
37. A primary lung carcinoma producing alpha-fetoprotein, carcinoembryonic antigen, and human chorionic gonadotropin. Immunohistochemical and biochemical studies.
Yoshimoto T; Higashino K; Hada T; Tamura S; Nakanishi K; Mitsunobu M; Uematsu K; Matsuoka T; Taketa K
Cancer; 1987 Dec; 60(11):2744-50. PubMed ID: 2445464
[TBL] [Abstract][Full Text] [Related]
38. Tumor markers in carcinoma and premalignant states of the stomach in humans.
Skinner JM; Whitehead R
Eur J Cancer Clin Oncol; 1982 Mar; 18(3):227-35. PubMed ID: 6178591
[TBL] [Abstract][Full Text] [Related]
39. Tumor-associated antigen levels (carcinoembryonic antigen, human chorionic gonadotropin, and alpha-fetoprotein) antedating the diagnosis of cancer in the Framingham study.
Williams RR; McIntire KR; Waldmann TA; Feinleib M; Go VL; Kannel WB; Dawber TR; Castelli WP; McNamara PM
J Natl Cancer Inst; 1977 Jun; 58(6):1547-51. PubMed ID: 68118
[TBL] [Abstract][Full Text] [Related]
40. The significance of measurement of human placental lactogen, human chorionic gonadotropin, and carcinoembryonic antigen in patients with ovarian carcinoma.
Samaan NA; Smith JP; Rutledge FN; Schultz PN
Am J Obstet Gynecol; 1976 Sep; 126(2):186-9. PubMed ID: 183504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
